- Home
- KXIN vs OGEN Comparison
KXIN vs OGEN Comparison
Compare KXIN & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- OGEN
- Stock Information
- Founded
- KXIN 2015
- OGEN 1996
- Country
- KXIN China
- OGEN United States
- Employees
- KXIN N/A
- OGEN N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- KXIN Consumer Discretionary
- OGEN Health Care
- Exchange
- KXIN Nasdaq
- OGEN Nasdaq
- Market Cap
- KXIN 10.5M
- OGEN 4.5M
- IPO Year
- KXIN N/A
- OGEN N/A
- Fundamental
- Price
- KXIN $0.16
- OGEN $0.34
- Analyst Decision
- KXIN
- OGEN
- Analyst Count
- KXIN 0
- OGEN 0
- Target Price
- KXIN N/A
- OGEN N/A
- AVG Volume (30 Days)
- KXIN 90.2M
- OGEN 389.1K
- Earning Date
- KXIN 01-01-0001
- OGEN 11-07-2024
- Dividend Yield
- KXIN N/A
- OGEN N/A
- EPS Growth
- KXIN N/A
- OGEN N/A
- EPS
- KXIN N/A
- OGEN N/A
- Revenue
- KXIN $12,679,000.00
- OGEN $7,466.00
- Revenue This Year
- KXIN N/A
- OGEN N/A
- Revenue Next Year
- KXIN N/A
- OGEN N/A
- P/E Ratio
- KXIN N/A
- OGEN N/A
- Revenue Growth
- KXIN N/A
- OGEN N/A
- 52 Week Low
- KXIN $0.06
- OGEN $0.29
- 52 Week High
- KXIN $3.55
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- KXIN 49.05
- OGEN 37.15
- Support Level
- KXIN $0.16
- OGEN $0.29
- Resistance Level
- KXIN $0.19
- OGEN $0.45
- Average True Range (ATR)
- KXIN 0.07
- OGEN 0.04
- MACD
- KXIN -0.01
- OGEN 0.02
- Stochastic Oscillator
- KXIN 4.65
- OGEN 28.88
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.